Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer

Annals of Internal Medicine

Volumn 131, Issue 11, 1999, Pages 805-812

  Cagir, Burt ^a   Gelmann, Alyssa ^a   Park, Jason ^a   Fava, Tracy ^a   Tankelevitch, Alexander ^a   Bittner, Edwin W ^a   Weaver, Eric J ^a   Palazzo, Juan P ^a   Weinberg, David ^a   Fry, Robert D ^a   Waldman, Scott A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GUANYLATE CYCLASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033534114     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-11-199912070-00002     Document Type: Article

References (36)

1. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990 CA Cancer J Clin. 1990;40:9-26.
2. Greenwald P. Colon cancer overview. Cancer. 1992:70(5 Suppl):1206-15.
3. Cresanta JL. Epidemiology of cancer in the United States. Prim Care. 1992; 19:419-41.
4. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer. 1996;78:918-26.
5. Beatty JD. Immunotherapy of colorectal cancer. Cancer. 1992;75(5 Suppl): 1425-33.
6. Sloane JP. Molecules and micrometastases. Lancet. 1995;345:1255-6.
7. Fuchs CS, Mayer RJ. Adjuvant chemotherapy for colon and recta cancer. Semin Oncol. 1995;22:472-87.
8. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-8.
9. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324:709-15.
10. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adiuvant Breast ana Bowel Project protocol C-03. J Clin Oncol. 1993; 11: 1879-87.
11. Abati A, Liotta LA. Looking forward in diagnostic pathology: the molecular superhighway [Editorial]. Cancer. 1996;78:1-3.
12. Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet. 1995:345:1257-9.
13. Rubio CA, Emas S, Nylander G. A critical reappraisal of Dukes' classification. Surg Gynecol Obstet. 1977;145:682-4.
14. Carrithers SL, Parkinson SJ, Goldstein S, Park P, Robertson DC, Waldman SA. Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology. 1994;107:1653-61.
15. Carrithers SL, Parkinson SJ, Goldstein SD, Park PK, Urbanski RW, Waldman SW. Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors. Dis Colon Rectum. 1996;39:171-81.
16. Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, et al. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci U S A. 1996;93: 14827-32.
17. Waldman SA, Cagir B, Rakinic J, Fry RD, Goldstein SD, Isenberg G, et al. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer. Dis Colon Rectum. 1996;41:310-5.
18. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998;339:223-8.
19. Kroczek RA. Southern and northern analysis. J Chromatogr. 1993;618:133-45.
20. Drewett JG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev. 1994;15:135-62.
21. Guarino A, Cohen MB, Overmann G, Thompson MR, Giannella RA. Binding of E. coli heat-stable enterotoxin to rat intestinal brush borders and to basolateral membranes. Dig Dis Sci. 1987;32:1017-26.
22. Almenoff JS, Williams SI, Scheving LA, Judd AK, Schoolnik GK, Ligand-based histochemical localization and capture of cells expressing heat-stable enterotoxin receptors. Mol Microbiol. 1993;8:865-73.
23. de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer. 1992;66: 523-7.
24. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery. 1996;119:397-402.
25. Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst. 1993;85:493-8.
26. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994;73:563-9.
27. Goldenberg DM, Sharkey RM, Primus FJ. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens. Cancer. 1978;42(3 Suppl):1546-53.
28. Bordes M, Michiels R, Martin F. Detection by immunofluorescence of carcinoembryonic antigen in colonic carcinoma, other malignant or benign tgmours and non-cancerous tissues. Digestion. 1973;9:106-15.
29. Bostick PJ, Hoon DS, Cote RJ. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer [Letter]. N Engl J Med. 1998;339:1643-4.
30. Goldstein NS, Sanford W, Coffey M, Layfield U. Lympn node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106:209-16.
31. Merrie AE, Yun K, McCall JL. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer [Letter]. N Engl J Med. 1998;339:1642.
32. Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schliiriok G, et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol. 1997;15:2701-8.
33. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol. 1998;16:2632-40.
34. Ghossein RA. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer [Letter]. N Engl J Med. 1998;339:1642-3.
35. Waldman SA, Barber M, Pearlman J, Park J, George R, Parkinson SJ. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro. Cancer Epidemiol Biomarkers Prev. 1998;7:505-14.
36. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P. et al. Allelic loss of chromosome 18q and prognosis in co'orectal cancer. N Engl J Med. 1994;331:213-21.